Cost vs Efficacy
| Regimen | Biomarker | Cost/cycle ↓ | Cycle | PFS ↕ | OS ↕ | Est. cycles | Course cost ↕ | Evidence |
|---|---|---|---|---|---|---|---|---|
Carboplatin and Ifosfamide Variant #01 | — | R 11 094 | 21d | — | — | ~4 | ~R 44 376 indirect | — |
Cisplatin and Gemcitabine (GC) Variant #01 | — | R 3 933 | 21d | — | ~10.3 mo | ~6 | ~R 23 595 PFS proxy · indirect | 1 |
Observation Partial | — | — | — | — | — | — | — | 2 |
Radiation therapy N/A - radiation | — | — | 49d | — | — | — | — | 3 |
4 of 4 regimens shown